Reyna R, Maruyama J, Mantlo E, Manning J, Taniguchi S, Makishima T
Biomedicines. 2022; 10(10).
PMID: 36289695
PMC: 9598517.
DOI: 10.3390/biomedicines10102433.
Melnik L
Curr Top Microbiol Immunol. 2022; 440:111-145.
PMID: 36253593
DOI: 10.1007/82_2022_261.
Brinkmann N, Hoffmann C, Wurr S, Pallasch E, Hinzmann J, Ostermann E
Viruses. 2022; 14(9).
PMID: 36146793
PMC: 9506377.
DOI: 10.3390/v14091986.
Salam A, Duvignaud A, Jaspard M, Malvy D, Carroll M, Tarning J
PLoS Negl Trop Dis. 2022; 16(3):e0010289.
PMID: 35353804
PMC: 9000057.
DOI: 10.1371/journal.pntd.0010289.
Merabet O, Pietrosemoli N, Perthame E, Armengaud J, Gaillard J, Borges-Cardoso V
Viruses. 2022; 14(3).
PMID: 35337059
PMC: 8953476.
DOI: 10.3390/v14030652.
RIG-I and MDA5 Protect Mice From Pichinde Virus Infection by Controlling Viral Replication and Regulating Immune Responses to the Infection.
Brisse M, Huang Q, Rahman M, Di D, Liang Y, Ly H
Front Immunol. 2021; 12:801811.
PMID: 34925387
PMC: 8677829.
DOI: 10.3389/fimmu.2021.801811.
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.
Lingas G, Rosenke K, Safronetz D, Guedj J
PLoS Comput Biol. 2021; 17(1):e1008535.
PMID: 33411731
PMC: 7817048.
DOI: 10.1371/journal.pcbi.1008535.
Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
Salu O, Amoo O, Shaibu J, Abejegah C, Ayodeji O, Musa A
Pan Afr Med J. 2020; 36:253.
PMID: 33014249
PMC: 7519794.
DOI: 10.11604/pamj.2020.36.253.22104.
Brothers in Arms: Structure, Assembly and Function of Nucleoprotein.
Papageorgiou N, Spiliopoulou M, Nguyen T, Vaitsopoulou A, Laban E, Alvarez K
Viruses. 2020; 12(7).
PMID: 32708976
PMC: 7411964.
DOI: 10.3390/v12070772.
Vaccine platforms for the prevention of Lassa fever.
Purushotham J, Lambe T, Gilbert S
Immunol Lett. 2019; 215:1-11.
PMID: 31026485
PMC: 7132387.
DOI: 10.1016/j.imlet.2019.03.008.
Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells.
Schaeffer J, Carnec X, Reynard S, Mateo M, Picard C, Pietrosemoli N
PLoS Pathog. 2018; 14(11):e1007430.
PMID: 30419076
PMC: 6258464.
DOI: 10.1371/journal.ppat.1007430.
Current research for a vaccine against Lassa hemorrhagic fever virus.
Warner B, Safronetz D, Stein D
Drug Des Devel Ther. 2018; 12:2519-2527.
PMID: 30147299
PMC: 6097522.
DOI: 10.2147/DDDT.S147276.
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C
J Virol. 2018; 92(12).
PMID: 29593043
PMC: 5974477.
DOI: 10.1128/JVI.02230-17.
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.
Hallam H, Hallam S, Rodriguez S, Barrett A, Beasley D, Chua A
NPJ Vaccines. 2018; 3:11.
PMID: 29581897
PMC: 5861057.
DOI: 10.1038/s41541-018-0049-5.
A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
McElroy A, Akondy R, Harmon J, Ellebedy A, Cannon D, Klena J
J Infect Dis. 2017; 215(12):1862-1872.
PMID: 28863472
PMC: 5853890.
DOI: 10.1093/infdis/jix201.
Moving Lassa Fever Research and Care Into the 21st Century.
Fischer 2nd W, Wohl D
J Infect Dis. 2017; 215(12):1779-1781.
PMID: 28863471
PMC: 5853919.
DOI: 10.1093/infdis/jix206.
Immunobiology of Ebola and Lassa virus infections.
Prescott J, Marzi A, Safronetz D, Robertson S, Feldmann H, Best S
Nat Rev Immunol. 2017; 17(3):195-207.
PMID: 28111475
DOI: 10.1038/nri.2016.138.
Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses.
Meyer B, Ly H
J Virol. 2016; 90(8):3810-3818.
PMID: 26865707
PMC: 4810556.
DOI: 10.1128/JVI.03049-15.
Differential Inhibition of Macrophage Activation by Lymphocytic Choriomeningitis Virus and Pichinde Virus Is Mediated by the Z Protein N-Terminal Domain.
Xing J, Chai Z, Ly H, Liang Y
J Virol. 2015; 89(24):12513-7.
PMID: 26423945
PMC: 4665234.
DOI: 10.1128/JVI.01674-15.
Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
Huang C, Kolokoltsova O, Yun N, Seregin A, Ronca S, Koma T
J Virol. 2015; 89(14):7079-88.
PMID: 25926656
PMC: 4473569.
DOI: 10.1128/JVI.00526-15.